Global Occupational Respiratory Disorders Market, By Disease Type (Asbestosis, Black Lung Disease, Silicosis, Byssinosis, Hypersensitivity Pneumonitis, Work-Related Asthma and Others), Cause (Organic and Inorganic), Drugs Type (Mycolytics, Antibiotics, Corticosteroids, Antihistmains and Others), Severity (Acute and Chronic), Route of Administration (Oral, Nasal, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers, Research Institute, and, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.
Occupational Respiratory Disorders Market Analysis and Size
An increase in the prevalence of occupational respiratory disorders, increasing smoking population, and rising air pollution will assist in encouraging the growth of the market. However, strict pricing and reimbursement policies, high cost of drugs, will restraint the occupational respiratory disorders market.
Data Bridge Market Research analyses that the global occupational respiratory disorders market, which was USD 9,308.01 million in 2022, is expected to reach USD 15,174.80 million by 2030, and is expected to undergo a CAGR of 6.30% during the forecast period 2023-2030. This indicates that the asbestosis segment dominates the disease type segment of the global occupational respiratory disorders market owing to the advancements in technology that have led to the development of rapid and implant drugs and treatments for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Occupational Respiratory Disorders Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Disease Type (Asbestosis, Black Lung Disease, Silicosis, Byssinosis, Hypersensitivity Pneumonitis, Work-Related Asthma and Others), Cause (Organic and Inorganic), Drugs Type (Mycolytics, Antibiotics, Corticosteriods, Antihistmains and Others), Severity (Acute and Chronic), Route of Administration (Oral, Nasal, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers, Research Institute, and, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GlaxoSmithKline Plc (U.K.), AstraZeneca (U.K.), Novartis AG (Switzerland),Johnson & Johnson (U.S.), Mylan N.V, ( U.S.), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Limited (Israel), Gilead Sciences, Inc ( U.S.), Bayer AG (Germany), Pfizer Inc. ( U.S.), Bristol-Myers Squibb ( U.S.), Merck & Co. ( U.S.), Sanofi (France), Mallinckrodt plc(U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Inc ( U.S.)
|
|
Market Opportunities
|
|
Market Definition
Occupational respiratory disorders, also known as work-related respiratory diseases, are a group of conditions that are caused or exacerbated by exposure to hazardous substances or conditions in the workplace. These disorders affect the respiratory system, including the lungs, airways, and related structures.
Global Occupational Respiratory Disorders Market Dynamics
Drivers
- Increasing Awareness
There has been a growing awareness among workers and employers about the risks associated with occupational respiratory disorders. This has led to an increased demand for preventive measures and early diagnosis of respiratory disorders, driving the market growth.
- Increasing Industrialization
The rapid industrialization in emerging economies has resulted in a higher number of workers being exposed to occupational respiratory hazards. This has created a greater demand for respiratory protective equipment and monitoring devices, driving the market growth.
- Occupational Health and Safety Initiatives
Several organizations and companies have started implementing comprehensive occupational health and safety programs to protect their workforce from respiratory hazards. This includes regular health check-ups, training on the proper use of respiratory protective equipment, and monitoring of workplace air quality. These initiatives have contributed to the growth of the market.
Opportunities
- Technological Advancements
The development of advanced respiratory monitoring devices, such as portable spirometers, wearable devices, and real-time air quality monitoring systems, has significantly contributed to the growth of the market. These devices offer accurate and real-time monitoring of respiratory parameters, aiding in early diagnosis and treatment of respiratory disorders.
- Growing Healthcare Expenditure
The increasing healthcare expenditure globally has led to improved access to healthcare facilities and diagnostic services. This has positively impacted the demand for diagnostic tests and treatment options for occupational respiratory disorders, driving the market growth.
Restraints/Challenges
- Workplace Monitoring and Measurement Equipment
This segment includes the development and sale of monitoring and measurement equipment that assesses air quality, particulate matter levels, and exposure to harmful substances. Innovations in real-time monitoring are driving growth in this area.
-
Regulatory Compliance Solutions
Companies often invest in software and solutions that help them navigate and comply with occupational health and safety regulations related to respiratory hazards. These solutions assist in managing compliance records and safety data.
The global occupational respiratory disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global occupational respiratory disorders market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2021, 3M announced the launch of their new Powered Air Purifying Respirator (PAPR) system called Versaflo TR-600. This system is designed to provide respiratory protection for workers in various industries, including those at risk of occupational respiratory disorders
- In July 2021, Honeywell announced the expansion of their respiratory protection product line with the introduction of the North 7700 Series Half Mask. This mask is designed to provide a comfortable and secure fit, helping to protect workers from airborne contaminants in occupational settings
Global Occupational Respiratory Disorders Market Scope
The global occupational respiratory disorders market is segmented on the basis of disease type, cause, drugs type, severity, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Type
- Asbestosis
- Black Lung Disease
- Silicosis
- Byssinosis
- Hypersensitivity Pneumonitis
- Work-Related Asthmaa
- Others
Cause
- Organic
- Inorganic
Drugs Type
- Mycolytics
- Antibiotics
- Corticosteriods
- Antihistmains
- Others
Severity
- Acute
- Chronic
Route of Administration
- Oral
- Nasal
- Parenteral
End User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Research Institute
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Global Occupational Respiratory Disorders Market Analysis/Insights
The global occupational respiratory disorders market is analyzed and market size insights and trends are provided by country, disease type, cause, drugs type, severity, route of administration, end user, and distribution channel as referenced above.
The countries covered in the global occupational respiratory disorders market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global occupational respiratory disorders market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the occupational respiratory disorders products, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Occupational Respiratory Disorders Market Share Analysis
The global occupational respiratory disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global occupational respiratory disorders market.
Some of the major players operating in the global occupational respiratory disorders market are:
- GlaxoSmithKline Plc (U.K.)
- AstraZeneca (U.K.)
- Novartis AG (Switzerland)
- Johnson & Johnson (U.S.)
- Mylan N.V, (U.S.)
- Boehringer Ingelheim GmbH (Germany)
- Teva Pharmaceutical Industries Limited (Israel)
- Gilead Sciences, Inc (U.S.)
- Bayer AG: Leverkusen, Germany
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb (U.S.)
- Merck & Co. (U.S.)
- Sanofi (France)
- Mallinckrodt plc(U.K.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Vertex Pharmaceuticals Inc (U.S.)
SKU-